WHO ICTRP trial
BENITA study on the use of bendamustine in the therapy of malignant lymphomas
DRKS00012312 · German Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | DRKS00012312 |
|---|---|
| Public title | BENITA study on the use of bendamustine in the therapy of malignant lymphomas |
| Scientific title | BENITA study on the use of bendamustine in the therapy of malignant lymphomas - BENITA |
| Primary sponsor | AxioNovo Gmbh |
| Registry | German Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | observational |
| Countries | Germany |
| Conditions | Malignant lymphoma C85.7 C91.1 C90.0;Other specified types of non-Hodgkin lymphoma;Chronic lymphocytic leukaemia of B-cell type;Multiple myeloma;C85.7;C91.1;C90.0 |
| Interventions | Group 1: Treatment with bendamustine according to the SmPC in the context of an observational study. Collection of demographic and medical history data, health status, dosage and regimen, concomitant diagnostics, treatment discontinuations… |
| Registration date | Jun 29, 2017 |
| Target size | 500 |
| Secondary IDs | U1111-1195-2982 |
| Registry page | drks.de |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: